Honestly, Nutra Pharma could raise the A/S up to 20 billion and I still would not give a darn, doesn't worry me one bit! Just like my Apple example in post # 31897, having a very high available "shall/may issue" authorized share count can be a very smart and very strategic move for a company who knows what they are doing! The only time when having a huge A/S amount is a bad thing is mostly for brand new startups that do not have any cash reserves, can't get traditional financing, no revenue, no products in market and/or no available services to provide, as well as no customers or clientele lined up! An established company like Nutra Pharma that is 17 years old, with a revenue producing product lineup already in the market place and with more on the way, can do just fine with a high A/S count! Established companies like Apple have a high A/S count basically to act as a proverbial "carrot on a stick" to dangle and entice future business partners and investors. Also, once those partners and investors come on board, then Apple can pledge those authorized shares as collateral/payback for loans, favors, consultancies, collaborations, non competitive clauses, legal help, marketing and brand awareness and so on and so forth, the possibilities are endless! So, the whole idea then is to use the "promise" of those A/S to lure in outside help and/or money, but you actually repay them with your increased revenues instead of with those precious authorized shares! The most successful publically traded companies do this quite often and they do this because it works! Nutra Pharma Corp is not some brand new company who has no clue what they are doing! No, they are now a mature established biotech who has grown a lot and learned tremendously from past mistakes! They are a company who takes their role and position very seriously and this is obvious to anyone who knows anything about running a business here on Ihub! Myself included!
News 
Market Data 
Discover 
